Michael Ciraolo
Keine laufenden Positionen mehr
Karriereverlauf von Michael Ciraolo
Ehemalige bekannte Positionen von Michael Ciraolo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NEUROTROPE, INC. | Geschäftsführer | 01.04.2019 | 31.10.2019 |
General Counsel | 01.04.2019 | 31.10.2019 | |
OVID THERAPEUTICS INC. | Corporate Officer/Principal | 01.06.2015 | 31.03.2019 |
FOREST LABORATORIES, INC. | Direktor/Vorstandsmitglied | - | - |
Baker Botts LLP
Baker Botts LLP Miscellaneous Commercial ServicesCommercial Services Baker Botts LLP provides legal services. Its services include antitrust and compensation law, corporate, enforcement and investigations, environmental law, intellectual property, litigation, projects, real estate and construction, regulatory, and tax. The firm renders its services to banking and finance industry, energy and natural resources, manufacturing, and technological industries. The company was founded by Peter Gray in 1840 and is headquartered in Houston, Texas. | Corporate Officer/Principal | - | - |
ArentFox Schiff LLP
ArentFox Schiff LLP Miscellaneous Commercial ServicesCommercial Services ArentFox Schiff LLP provides legal services. The firm offers their services in areas including the intellectual property, real estate, telecommunications, healthcare, automotive, sports, white collar, international trade, bankruptcy, and complex litigation. The company was founded in 1942 and is headquartered in Washington, DC. | Corporate Officer/Principal | - | - |
Ausbildung von Michael Ciraolo
State University of New York College at Brockport | Undergraduate Degree |
Stony Brook University | Doctorate Degree |
St. John's University School of Law | Graduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Saudi-Arabien | 2 |
Operativ
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
OVID THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
ArentFox Schiff LLP
ArentFox Schiff LLP Miscellaneous Commercial ServicesCommercial Services ArentFox Schiff LLP provides legal services. The firm offers their services in areas including the intellectual property, real estate, telecommunications, healthcare, automotive, sports, white collar, international trade, bankruptcy, and complex litigation. The company was founded in 1942 and is headquartered in Washington, DC. | Commercial Services |
Baker Botts LLP
Baker Botts LLP Miscellaneous Commercial ServicesCommercial Services Baker Botts LLP provides legal services. Its services include antitrust and compensation law, corporate, enforcement and investigations, environmental law, intellectual property, litigation, projects, real estate and construction, regulatory, and tax. The firm renders its services to banking and finance industry, energy and natural resources, manufacturing, and technological industries. The company was founded by Peter Gray in 1840 and is headquartered in Houston, Texas. | Commercial Services |
Neurotrope, Inc.
Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
Forest Laboratories, Inc.
Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Michael Ciraolo
- Erfahrung